Opdivo (Nivolumab) and Yervoy (Ipilimumab) in NSCLC and Melanoma: An Expansive ReviewCancer research in the 21st century has witnessed a significant paradigm shift.Category: ONCOLOGYCategory: MELANOMACategory: OPDIVOCategory: YERVOYCategory: NSCLC
